4.6 Article

Transcriptomic Profiling Analysis of Castration-Resistant Prostate Cancer Cell Lines Treated with Chronic Intermittent Hypoxia

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Bisphenol S promotes the progression of prostate cancer by regulating the expression of COL1A1 and COL1A2

Shengdi Liu et al.

Summary: This study found a novel method to predict the correlation between bisphenol and tumors. The results suggest that bisphenol may have potential effects on prostate cancer, and certain genes (such as COL1A1 and COL1A2) can predict the prognosis of prostate cancer.

TOXICOLOGY (2022)

Article Cell Biology

Integrin α11β1 is a receptor for collagen XIII

Jarkko Koivunen et al.

Summary: Collagen XIII is a transmembrane collagen expressed in mesenchymal tissues, and it interacts with integrin alpha 11 beta 1 to regulate bone homeostasis. The study showed that integrin alpha 11 beta 1 acts as a receptor for collagen XIII, mediating cell adhesion to specific collagenous motifs, and plays a role in maintaining bone homeostasis.

CELL AND TISSUE RESEARCH (2021)

Review Biochemistry & Molecular Biology

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature

Jan Korbecki et al.

Summary: Hypoxia plays a crucial role in the tumor microenvironment, affecting cancer processes. Changes in CXC chemokine expression induced by hypoxia have implications for angiogenesis, lymphangiogenesis, and recruitment of various cells to the tumor niche. Targeting the CXC chemokine system with drugs has potential in cancer therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Adaptation to Chronic-Cycling Hypoxia Renders Cancer Cells Resistant to MTH1-Inhibitor Treatment Which Can Be Counteracted by Glutathione Depletion

Christine Hansel et al.

Summary: This study reveals that improved antioxidant capacity in cancer cells contributes to increased radioresistance, potentially leading to acquired resistance to antineoplastic agents and ionizing radiation. By investigating the sensitivity of cancer cells to different hypoxia/reoxygenation stress conditions, the research suggests a potential strategy to enhance cancer cell sensitivity through multi-targeting approaches.

CELLS (2021)

Review Medicine, General & Internal

Prostate cancer

Shahneen Sandhu et al.

Summary: Management of prostate cancer is rapidly evolving with advances in understanding the genomic landscape, improved imaging methods, and personalised therapeutics targeting DNA repair pathways. The therapeutic framework for metastatic disease has shifted, with oligometastatic disease being evaluated for metastatic-directed therapies, and novel androgen pathway inhibitors showing significant survival benefits as first-line therapy for metastatic disease. Emerging research into molecular characterisation and novel therapeutics, such as targeted radioisotopes and immunotherapy, hold promise for improving patient outcomes.

LANCET (2021)

Article Respiratory System

Chronic intermittent hypoxia promoted lung cancer stem cell-like properties via enhancing Bach1 expression

Shengyu Hao et al.

Summary: Chronic intermittent hypoxia exposure enhances lung cancer metastatic potential and promotes lung CSC-like properties through activating mitochondrial ROS, partly mediated by Bach1.

RESPIRATORY RESEARCH (2021)

Article Oncology

Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer

Sung Eun Oh et al.

Summary: COL7A1 is upregulated in gastric cancer tissue and its expression is associated with patient prognosis and distant metastasis. It may serve as a novel biomarker with diagnostic and therapeutic value.

PATHOLOGY & ONCOLOGY RESEARCH (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Bad neighbours: hypoxia and genomic instability in prostate cancer

Jack Ashton et al.

BRITISH JOURNAL OF RADIOLOGY (2020)

Article Multidisciplinary Sciences

ONECUT2 is a driver of neuroendocrine prostate cancer

Haiyang Guo et al.

NATURE COMMUNICATIONS (2019)

Review Chemistry, Multidisciplinary

The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development

Anna Sorushanova et al.

ADVANCED MATERIALS (2019)

Review Peripheral Vascular Disease

miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target

Marcin Serocki et al.

ANGIOGENESIS (2018)

Article Biochemistry & Molecular Biology

Intermittent hypoxia induces a metastatic phenotype in breast cancer

Anna Chen et al.

ONCOGENE (2018)

Review Oncology

The hypoxic tumour microenvironment

Varvara Petrova et al.

ONCOGENESIS (2018)

Review Oncology

Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings

Avelino Fraga et al.

CLINICAL GENITOURINARY CANCER (2015)

Article Urology & Nephrology

Normoxic regulation of HIF-1α in prostate cancer

Weranja K. B. Ranasinghe et al.

Nature Reviews Urology (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Review Oncology

Hypoxia and the extracellular matrix: drivers of tumour metastasis

Daniele M. Gilkes et al.

NATURE REVIEWS CANCER (2014)

Article Oncology

Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis

Daniele M. Gilkes et al.

CANCER RESEARCH (2013)

Article Medicine, Research & Experimental

ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer

Changmeng Cai et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Genetics & Heredity

RNA sequencing: advances, challenges and opportunities

Fatih Ozsolak et al.

NATURE REVIEWS GENETICS (2011)

Review Biochemistry & Molecular Biology

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

G. L. Semenza

ONCOGENE (2010)

Review Biotechnology & Applied Microbiology

Targeting the phosphoinositide 3-kinase pathway in cancer

Pixu Liu et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Oncology

Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype

Karl T. Butterworth et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Review Oncology

Drug resistance and the solid tumor microenvironment

Olivier Tredan et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

Article Oncology

Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases

Jacqueline Banyard et al.

CLINICAL CANCER RESEARCH (2007)

Review Multidisciplinary Sciences

Hypoxia signalling in cancer and approaches to enforce tumour regression

Jacques Pouyssegur et al.

NATURE (2006)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Oncology

Hypoxia - A key regulatory factor in tumour growth

AL Harris

NATURE REVIEWS CANCER (2002)

Article Oncology

Hypoxia in human prostate carcinoma -: An Eppendorf Po2 study

B Movsas et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)

Article Cell Biology

Tracking micrometastasis to multiple organs with lacZ-tagged CWR22R prostate carcinoma cells

JL Holleran et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)